<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03662646</url>
  </required_header>
  <id_info>
    <org_study_id>TASMAC-16-YW-0200-CTIL</org_study_id>
    <nct_id>NCT03662646</nct_id>
  </id_info>
  <brief_title>Circadian Rhythms in IBD Patients Upon Diagnosis</brief_title>
  <official_title>Clock Gene Disruption May be an Initial Manifestation of IBD.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      patients under the age of 15 years old upon diagnostic evaluation will be recruited .

      study population will comprise of two groups: newly diagnosed IBD patients and healthy
      controls.

      upon enrollment, subjects will fill out sleeping habits questioners, demographic data,
      medical history.

      blood samples will be drawn for CRP and clock gene expression in systemic WBC. intestinal
      biopsies will be snap frozen for clock gene extraction and amplification.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 31, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2018</completion_date>
  <primary_completion_date type="Actual">August 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>clock gene expression levels in intestinal mucosal samples and WBC peripheral blood.</measure>
    <time_frame>two years</time_frame>
    <description>PCR amplification levels</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <condition>Circadian Dysregulation</condition>
  <arm_group>
    <arm_group_label>IBD patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention performed- observational only</intervention_name>
    <description>no intervention performed- observational only</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>IBD patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients performing endoscopic procedures in our institute.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - patients admitted to perform endoscopic workup for gastrointestinal complaints.

        Exclusion Criteria:

          -  1. known and treated IBD. 2. current immunosupresive treatment. 3. genetic disorder.
             4. known immunodeficiency. 5. pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>yael weintraub, md</last_name>
    <phone>972-3-6974159</phone>
    <email>yaelwb@tlvmc.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gali Hgler-Price</last_name>
      <phone>972-3-694761</phone>
      <email>clintrials@tlvmc.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 5, 2018</study_first_submitted>
  <study_first_submitted_qc>September 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2018</study_first_posted>
  <last_update_submitted>September 5, 2018</last_update_submitted>
  <last_update_submitted_qc>September 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel-Aviv Sourasky Medical Center</investigator_affiliation>
    <investigator_full_name>michal roll</investigator_full_name>
    <investigator_title>Dr. Yael Weintraub</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
    <mesh_term>Chronobiology Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

